⌘K
Loading ticker…
As of 2026-08-24, Gevo, Inc. (GEVO) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 0.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
GEVO is held by 15 ETFs as of May 2026. Top owner: VDE at 0.05% weight, $6M notional. Top 3 carry $10M.
Held by 31 ETFs · $80M across latest filings · largest weight 1.84% (UPGR).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.12% |
| $370K |
| −0.05 pp |
| VTWV | 0.03% | $347K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $31K | — |
| MSSM | 0.00% | $24K | — |
| ITWO | 0.01% | $20K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GEVO Jan avg: -6.43% median: -8.89% win: 25% σ: 14.17% n: 4 2022-04-12 → 2026-07-31 | GEVO Feb avg: -11.07% median: -9.94% win: 0% σ: 6.80% n: 4 2022-04-12 → 2026-07-31 | GEVO Mar avg: 0.43% median: -15.27% win: 25% σ: 33.09% n: 4 2022-04-12 → 2026-07-31 | GEVO Apr avg: -18.81% median: -19.87% win: 0% σ: 9.59% n: 5 2022-04-12 → 2026-07-31 | GEVO May avg: 8.21% median: 11.21% win: 80% σ: 7.47% n: 5 2022-04-12 → 2026-07-31 | GEVO Jun avg: -12.03% median: -18.50% win: 40% σ: 23.81% n: 5 2022-04-12 → 2026-07-31 | GEVO Jul avg: 7.94% median: 4.27% win: 60% σ: 11.30% n: 5 2022-04-12 → 2026-07-31 | GEVO Aug avg: 12.92% median: 19.77% win: 75% σ: 27.87% n: 4 2022-04-12 → 2026-07-31 (current) | GEVO Sep avg: 20.83% median: 2.07% win: 50% σ: 59.36% n: 4 2022-04-12 → 2026-07-31 | GEVO Oct avg: 12.73% median: 9.04% win: 50% σ: 23.63% n: 4 2022-04-12 → 2026-07-31 | GEVO Nov avg: -8.81% median: -5.83% win: 25% σ: 14.78% n: 4 2022-04-12 → 2026-07-31 | GEVO Dec avg: 2.48% median: -1.94% win: 50% σ: 17.33% n: 4 2022-04-12 → 2026-07-31 |